OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The year in cardiovascular medicine 2021: dyslipidaemia
Lâle Tokgözoğlu, Carl E. Orringer, Henry N. Ginsberg, et al.
European Heart Journal (2021) Vol. 43, Iss. 8, pp. 807-817
Open Access | Times Cited: 15

Showing 15 citing articles:

Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28

Vegetarian Dietary Patterns and Cardiometabolic Risk in People With or at High Risk of Cardiovascular Disease
Tian Wang, Cynthia M. Kroeger, Sophie Cassidy, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2325658-e2325658
Open Access | Times Cited: 27

New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review
Iveta Merćep, Dominik Strikić, Ana Marija Slišković, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 839-839
Open Access | Times Cited: 30

Qingre Sanjie Formula alleviates atherosclerosis by promoting LXR-α/ABCG5/G8-mediated reverse cholesterol transport and bile acid synthesis
Xiao Li, Xianglong Huang, K.H. Song, et al.
Phytomedicine (2025), pp. 156691-156691
Closed Access

Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study
Lotte M. de Boer, Barbara A. Hutten, Aeilko H. Zwinderman, et al.
European Heart Journal (2022) Vol. 44, Iss. 16, pp. 1421-1428
Open Access | Times Cited: 19

Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia
Naif Saad ALGhasab, Federica Fogacci, Ashot Avagimyan, et al.
Expert Opinion on Pharmacotherapy (2024)
Closed Access | Times Cited: 2

2022 Saudi Guidelines for the Management of Dyslipidemia
Jamilah AlRahimi, Shukri AlSaif, Mirvat Alasnag, et al.
Heart Views (2023) Vol. 24, Iss. 2, pp. 67-92
Open Access | Times Cited: 6

Diabetic dyslipidemia impairs coronary collateral formation: An update
Ying Shen, Xiao Qun Wang, Yang Dai, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 7

Ultra-Sensitive Label-Free Biosensor for Triglyceride Detection Based on Exposed-core Optical Fiber
Xindi Zhang, Xue Zhou, Yanan Zhang, et al.
IEEE Transactions on Instrumentation and Measurement (2024) Vol. 73, pp. 1-6
Closed Access | Times Cited: 1

The Atlas of cardiovascular disease in Europe and a focus on frailty and cardiovascular risk
Filippo Crea
European Heart Journal (2022) Vol. 43, Iss. 8, pp. 703-705
Open Access | Times Cited: 6

Lipoprotein(a) and residual vascular risk in statin-treated patients with first acute ischemic stroke: A prospective cohort study
Lanjing Wang, Lijun Liu, Yanhong Zhao, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6

New prospects in treatment of dyslipidaemia – putting patient compliance first
Dominik Strikić, Ana Marija Slišković, Andro Vujević, et al.
Cardiologia Croatica (2022) Vol. 17, Iss. 9-10, pp. 279-279
Open Access

European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias
А. С. Алиева, Elena Usova, Olga Reutova
European Atherosclerosis Journal (2022) Vol. 1, Iss. 2, pp. 48-53
Open Access

Page 1

Scroll to top